| Date | Form | Description | Docs | XBRL | Pages |
| 08/18/17 | 8-K | Current report filing |
|
2 | |
| 08/08/17 | DEF 14A | Definitive proxy statements |
|
37 | |
| 07/25/17 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 07/25/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/21/17 | 8-K | Current report filing |
|
3 | |
| 07/12/17 | 8-K | Current report filing |
|
3 | |
| 06/22/17 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 | |
| 06/22/17 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 | |
| 06/06/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/05/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...